Area:
Pharmacology, Neuroscience Biology
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Susan R. George is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2004 — 2013 |
George, Susan R |
R01Activity Code Description: To support a discrete, specified, circumscribed project to be performed by the named investigator(s) in an area representing his or her specific interest and competencies. |
Receptors Mediating Drug Dependence
DESCRIPTION (provided by applicant): Our approach to understanding drug addiction has targeted the dopamine and opioid systems as among the major transmitters having a role in the reinforcing effects of drugs of abuse. The actions of these transmitters are mediated by receptors that belong to the G protein coupled receptor (GPCR) family and form direct or indirect targets of drug abuse. Thus, since the receptors are central to the homeostasis, regulation and signaling by these transmitters, our work has focused on the elucidation of the function of dopamine and opioid receptors. Our studies of these receptor systems revealed that they exist and function within homoooligomeric and heterooligomeric complexes. We have established that there is specificity of both homo- and hetero-oligomerization allowing certain receptors to either interact or stay separate. We are now involved in determining the rules governing the specificity underlying receptor-receptor interactions. Thus far, we have determined that transmembrane domain four is a critical part of the dimer interface but additional structural domains also participate in oligomer formation. We will investigate this using a variety of techniques, including crosslinking, immunoprecipitation, fluorescence resonance energy transfer, laser confocal microscopy and a novel methodology we have developed. We will determine the forms of the receptors (monomers, dimers, oligomers) that exist at the cell surface. In addition, we will determine whether the receptors are contained in membrane microdomains such as lipid rafts. We have shown that receptor heterooligomerization can result in entirely novel signaling and pharmacological properties distinct from that of either receptor partner. We aim to determine the physiological role of these heterooligomerization complexes in native brain tissue, neuronal cultures and transfected cells. We are specifically interested in investigating and comparing the receptor structural determinants underlying both homo and heterooligomerization. Oligomerization represents a highly significant complexity in receptor signal transduction mechanisms that is critical to study, not only to further the understanding of physiological processes, but to eventually incorporate these aspects into the search for new therapeutic agents.
|
1 |